Suppr超能文献

过氧化物酶体 β-氧化调节全身代谢、炎症活力和非酒精性脂肪性肝病的发病机制。

Peroxisomal β-oxidation regulates whole body metabolism, inflammatory vigor, and pathogenesis of nonalcoholic fatty liver disease.

机构信息

Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

Division of Immunobiology, Cincinnati Children's Hospital Medical Center (CCHMC), Cincinnati, Ohio, USA.

出版信息

JCI Insight. 2018 Mar 22;3(6):93626. doi: 10.1172/jci.insight.93626.

Abstract

Nonalcoholic fatty liver disease (NAFLD), a metabolic predisposition for development of hepatocellular carcinoma (HCC), represents a disease spectrum ranging from steatosis to steatohepatitis to cirrhosis. Acox1, a rate-limiting enzyme in peroxisomal fatty acid β-oxidation, regulates metabolism, spontaneous hepatic steatosis, and hepatocellular damage over time. However, it is unknown whether Acox1 modulates inflammation relevant to NAFLD pathogenesis or if Acox1-associated metabolic and inflammatory derangements uncover and accelerate potential for NAFLD progression. Here, we show that mice with a point mutation in Acox1 (Acox1Lampe1) exhibited altered cellular metabolism, modified T cell polarization, and exacerbated immune cell inflammatory potential. Further, in context of a brief obesogenic diet stress, NAFLD progression associated with Acox1 mutation resulted in significantly accelerated and exacerbated hepatocellular damage via induction of profound histological changes in hepatocytes, hepatic inflammation, and robust upregulation of gene expression associated with HCC development. Collectively, these data demonstrate that β-oxidation links metabolism and immune responsiveness and that a better understanding of peroxisomal β-oxidation may allow for discovery of mechanisms central for NAFLD progression.

摘要

非酒精性脂肪性肝病 (NAFLD) 是肝细胞癌 (HCC) 发展的代谢倾向,代表了从脂肪变性到脂肪性肝炎再到肝硬化的疾病谱。过氧化物酶体脂肪酸β-氧化的限速酶 Acox1 调节代谢、自发性肝脂肪变性和随时间推移的肝细胞损伤。然而,尚不清楚 Acox1 是否调节与 NAFLD 发病机制相关的炎症,或者 Acox1 相关的代谢和炎症紊乱是否揭示并加速了 NAFLD 进展的潜力。在这里,我们表明,过氧化物酶体脂肪酸β-氧化的限速酶 Acox1 中的点突变 (Acox1Lampe1) 表现出改变的细胞代谢、改变的 T 细胞极化和加剧的免疫细胞炎症潜力。此外,在短暂的肥胖饮食应激下,与 Acox1 突变相关的 NAFLD 进展导致通过诱导肝细胞、肝炎症和与 HCC 发展相关的基因表达的显著增加的深刻组织学变化,显著加速和加剧肝细胞损伤。总的来说,这些数据表明β-氧化将代谢和免疫反应联系起来,更好地理解过氧化物酶体β-氧化可能为发现 NAFLD 进展的核心机制提供线索。

相似文献

8
Nonalcoholic fatty liver disease and hepatocellular carcinoma.非酒精性脂肪性肝病与肝细胞癌
Metabolism. 2016 Aug;65(8):1151-60. doi: 10.1016/j.metabol.2016.01.010. Epub 2016 Jan 23.
9
miR-222 targets ACOX1, promotes triglyceride accumulation in hepatocytes.miR-222 靶向 ACOX1,促进肝细胞中甘油三酯的积累。
Hepatobiliary Pancreat Dis Int. 2019 Aug;18(4):360-365. doi: 10.1016/j.hbpd.2019.05.002. Epub 2019 May 13.

引用本文的文献

1
Peroxisome Dysfunction and Steatotic Liver Disease.过氧化物酶体功能障碍与脂肪性肝病
Int J Mol Sci. 2025 Aug 27;26(17):8303. doi: 10.3390/ijms26178303.

本文引用的文献

7
Hepatic TLR4 signaling in obese NAFLD.肥胖非酒精性脂肪性肝病中的肝脏Toll样受体4信号传导
Am J Physiol Gastrointest Liver Physiol. 2015 Aug 15;309(4):G270-8. doi: 10.1152/ajpgi.00304.2014. Epub 2015 Jun 25.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验